A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy
| Status: | Archived |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2010 |
| End Date: | June 2011 |
A Phase 2, Randomized, Blinded, 5-period Cross-over, Placebo and Active Controlled, Multicenter, Dose-finding Study Comparing Single Doses of Formoterol 2.25 µg, 4.5 µg, and 9 µg Delivered Via Symbicort pMDI and Foradil® 12 µg Evaluating the Relative Bronchodilating Effects and Safety in Children
This purpose of the study is to investigate the bronchodilating effects of 3 different
dosages of formoterol given in combination with budesonide as Symbicort pMDI.
A Phase 2, randomized, blinded, 5-period cross-over, placebo and active controlled,
multicenter, dose-finding study comparing single doses of formoterol 2.25 µg, 4.5 µg, and 9
µg delivered via Symbicort pMDI and Foradil® 12 µg evaluating the relative bronchodilating
effects and safety in children.
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials